chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started to feel very weak; Can barely move the body; Almost can not walk; 100.2°  fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Started to feel very weak), MOBILITY DECREASED (Can barely move the body), GAIT DISTURBANCE (Almost can not walk) and PYREXIA (100.2°  fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059E21O, 021M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Sep-2021, the patient experienced ASTHENIA (Started to feel very weak), MOBILITY DECREASED (Can barely move the body), GAIT DISTURBANCE (Almost can not walk) and PYREXIA (100.2°  fever). At the time of the report, ASTHENIA (Started to feel very weak), MOBILITY DECREASED (Can barely move the body), GAIT DISTURBANCE (Almost can not walk) and PYREXIA (100.2°  fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Sep-2021, Body temperature: 100.2 (High) High.         No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Follow up received contain  no new information. On 12-Sep-2021: Follow up received contain updated event out case as recovered/resolved.
This spontaneous report as received from a nurse refers to an unspecified number of unspecified patients of unknown age and gender. On unknown dates, the patients received dose of RECOMBIVAX HB, that had been improperly stored (lot #, expiration date, route, dose and frequency not provided). No adverse experience was reported. A telephone attempt to obtain follow-up information on 23-MAR-2015 was unsuccessful. The nurse could not supply the information regarding lot numbers, expiration dates and patient identification information at the time of the call. The reporter confirmed that there had been no reports of adverse events following administration of the vaccinations. This is one of several reports received from the same reporter. Additional information has been requested.
nausea; lost weight, and is now underweight; lost weight, and is now underweight; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 24 year-old female patient received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) at the age of 24 years as dose 2, single and administration date May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "nausea"; WEIGHT DECREASED (non-serious), UNDERWEIGHT (non-serious), outcome "unknown" and all described as "lost weight, and is now underweight".  Additional information: The reporter was asking about the booster dose of the vaccine for her 24 year old daughter. She asked if it is the same as the first 2 doses. She mentioned that her daughter experienced nausea after the first 2 doses, which she received in May2022. She also states that her daughter lost weight, and is now underweight, but unsure if she attributed that to the vaccine. The reporter asked that how long the vaccine protects people? She asked whether or not her daughter should get the booster dose due to her weight being so low, whether or not that was safe.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Uncontrollable screaming for 1 hour, projectile vomiting, fever of 102.1. Fever resolved after 24 hours, behavior abnormal for 5 days. Change in stools, fat globules, not seen before, for 2 weeks.
Headache, Myalgia, Fever, Chills and loss of appetite Narrative:
Swelling, redness & lump at site of injection x7d.  Now 2 weeks later still sm lump about 0.8 and sm dimple on skin.
pt recv vax 2DEC97 & same day pt exp silver dollar size redness, hot to touch, had a sore on the back of arm & had SOB;the reporting MD also noted pt was exp lt lower extremity pain @ time of vax;
1st advsere reaction: Patient reports after 2nd dose of moderna covid vaccine onset of chills body aches lasting 12hrs, Sxs resolved w/o medical intervention.   2nd adverse reaction: Patient received 1st dose Moderna on 12/29/20, 2nd dose on 1/28/21. Pt reports onset of sxs of congestion on 3/26/21. Patient tested for covid  positive  on 3/26/21 . Pt reports sxs had resolved as of 3/29/21. Infection control investigated tracing reporting patient contracted covid through community contact.
Rash of small red bumps starting on the chest and spreading up the next and across the back over 4 days to date
Evening arm was throbbing and warm from top of arm to elbow. Also had a headache.fever of 102.2 and had chills. Joint pain everywhere. Felt like she had the flu. Could not stay awake on 1/17/21  Is feeling better as of today.
Patient was given vaccine at Community Outreach event on 04/2/21. Mother was contacted on 4/6/21 concerning incomplete name on her consent. She advised that her son received the covvid vaccine and had gone to the ER on 4/6/21 with a swollen tongue. She stated that he was treated with Tylenol and Benadryl and released to come home that day. Spoke with mom on 4/7/21 and she stated that the patient was stable and his entire tongue was not swollen just a small area. She denied any issues with his airway or breathing from time of vaccine to time of follow up call.
According to his wife, patient began bruising all over, including on his feet, and developed a swollen gland on right side throat the next morning.
This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (tiny tiny" bumps that are hardly visible on top portion of feet and toes) and RASH PRURITIC ("tiny tiny" bumps are itchy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B214) for COVID-19 vaccination. The patient's past medical history included No adverse event (The patient's medical history was not provided.  On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Apr-2021, the patient experienced RASH PAPULAR (tiny tiny" bumps that are hardly visible on top portion of feet and toes) and RASH PRURITIC ("tiny tiny" bumps are itchy). At the time of the report, RASH PAPULAR (tiny tiny" bumps that are hardly visible on top portion of feet and toes) and RASH PRURITIC ("tiny tiny" bumps are itchy) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. OR Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Received vaccine at 1340 on 3/3/2021. Reported that she started to feel ill almost immediately after receiving  the injection. Symptoms include: Chest pain, SOB, difficultly breathing dizziness, and feverish.  patient was given Benadryl 50 mg injection and I dose of Epi Pen. Ambulance arrived about 20 min later and transported patient to local ED.
10/07/03- received smallpox vaccine. 10/17/03- started to experience fever (temp not taken), ha ("on and off" "migraine"), drowsiness, upper airway congestion, dizziness, fatigue, nausea, myalgia, and "red circular dots"- the rash started to spread to chest, back, and shoulders. 10/18/03- went to ER- labs, CXR, head CT- "all normal". 10/20/03- above sxs all dissipated.
The syringe malfunctioned & most of the dose was lost; The syringe malfunctioned & most of the dose was lost; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (The syringe malfunctioned & most of the dose was lost) and UNDERDOSE (The syringe malfunctioned & most of the dose was lost) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056A22A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 08-May-2022, the patient experienced DEVICE CONNECTION ISSUE (The syringe malfunctioned & most of the dose was lost) and UNDERDOSE (The syringe malfunctioned & most of the dose was lost). At the time of the report, DEVICE CONNECTION ISSUE (The syringe malfunctioned & most of the dose was lost) and UNDERDOSE (The syringe malfunctioned & most of the dose was lost) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Allergies with medications, food and other products was reported as unknown.  it was unknown if patient ever had COVID positive test or diagnosis.   Acute and Chronic illnesses at the time of vaccination was unknown.   No concomitant medication were reported.   A pharmacist over the weekend gave booster to a patient. The syringe malfunctioned & most of the dose was lost. Patient did not receive a new dose.  No treatment drug were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2022: Follow up document contain no new information.
I had vertigo and I went to an ENT 3 days after receiving vaccine and he did a treatment which took away the vertigo.
This spontaneous report was received from a medical assistant, referring to multiple unspecified patients. The patients' medical history, concurrent conditions, concomitant therapy, drug and allergy history were not provided. It was reported that on unknown dates, multiple unspecified patients were vaccinated with ROTATEQ, lot number L035510, expiration date 13-MAY-2017 (dose, frequency and administration route were not reported), for prophylaxis. At the reporting time, this vaccine was already expired and it was very possible that this vaccine had been administered. No adverse effects were reported. As on 19-JUL-2017, all telephone attempts to obtain follow up information had been unsuccessful. This is one of two cases from the same reporter. Sender's Comments: US-009507513-1705USA015628.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chest Tightness / Heaviness / Pain-Mild, Additional Details: patient's son was with patient in waiting area. patient's son alerted pharmacist that patient was not feeling well. observed patient having difficulty breathing. son requested 911 be called. 911 called for patient.
Got it, already got the two vaccines/ suspected vaccination failure; Got it (shingles); Is very painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got it, already got the two vaccines/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Got it (shingles)) and pain (Verbatim: Is very painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt date: 31-MAR-2023 This case was reported by patient via interactive digital media. The patient got it and it was very painful but the patient already got both vaccines one every three months. This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow up was not possible, as no contact details were available.
Dizzy, loss of consciousness x 30 seconds seizure - tonic clonic 30-60 sec. - oxygen provided and recovery vital signs monitored.
case was hospitalized.    2nd vaccine dose was 2/8/2021. Lot #011M20A
The patient reported experiencing flu-like symptoms and hiccups shortly after receiving the vaccine.  The patient describes the hiccups as sporadic, but were still present today, 11/12/2020.
Starting 4/6/2022 Fever of 104 Fever over 105 4/7/22 Started experiencing muscle pain in arms 4/8/22- 12pm stopped being able to walk. Took to ER Waited over hour for medical care instead took for outpatient lab work Was in episode of rhabdomyolysis needed IV treatment but ER "inundated" had to take home and treat with option of direct admission if needed
A few minutes after the vaccine was administered, I started to feel dizzy, my blood pressure went up to 168, they had to transfer me to the hospital by ambulance, after that I had diarrhea for a week, fever for several days. body aches and chills.
A 46 year old male inadvertently received an injection of Tetanus Toxoid on 11/14/00 and immediately, developed an injection site reaction characterized by redness, swelling, pain and induration. On 11/16/00, he returned to the clinic and was instructed to apply cold packs and to self-administer extra strength acetaminophen for the pain. The patient was seen again on 11/20/00 and he recovered. This is 1 of 5 patients from this facility who was administered Tetanus Toxoid intradermally.
As soon as vaccine was given, patient's arm began to swell and hives appeared. Swelling continued down the arm and Benadryl was given. Stayed in office approximately 45 minutes; swelling began to go down.
I had a UTI on 06/20/2021. I also joined a public pool by that time. I went to the doctor that day. I went to the doctor that day. They did a urine test, which indicated the infection. Then I had an ear infection in mid-July. I had 3 of them kind of in succession in both ears. It was not at the same time, it was one ear and then the other. I went to the doctor twice on august for the ear infections. They just prescribed some medications. Probably about a month ago I had shingles. I went to the doctor this month. They also prescribed a medication for that. In July I also had an injection for my knee. I still have mild pain in my ear.
Loss of taste; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) and ARTHRALGIA (Joint pain) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included CLONAZEPAM, GABAPENTIN and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced ARTHRALGIA (Joint pain). On 17-Apr-2021, the patient experienced AGEUSIA (Loss of taste). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Joint pain, at a dose of 1 dosage form and CODEINE PHOSPHATE (CODEIN) ongoing since an unknown date for Joint pain, at a dose of 1 dosage form. At the time of the report, AGEUSIA (Loss of taste) and ARTHRALGIA (Joint pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was  not applicable
Tested positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. It was reported that the patient took the second dose as well. The patient had no adverse reactions and was doing find now. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow up received on 25 Jul 2021. The event outcome was updated. The reporter details were updated and second dose details added.
Fever; Felt sweaty; Really nauseous; Arm was sore; Arm was bruised; Arm swollen; A spontaneous report was received from a consumer concerning herself, a 23-year-old, female patient who received Moderna's COVID-19 (mRNA-1273) vaccine and who experienced feeling sweaty [Sweaty], a sore and bruised arm [Administration site bruise/Injection site pain], fever/ongoing fever [Pyrexia], feeling nauseous [Nausea] and her arm was swollen [Peripheral swelling].   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 30-Dec-2020, one day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot unknown) intramuscularly for prophylaxis of COVID-19 infection.   The morning after receiving the vaccine, at approximately 3 AM, the patient felt sweaty and really nauseous. Later that same day, she experienced a fever and her arm was sore, bruised and swollen. She is still able to lift her arm.  Treatment for the event included acetaminophen.   Action taken with mRNA-1273 in response to the events was not provided.   The outcomes of the events, feeling sweaty [Sweaty], a sore and bruised arm [Administration site bruise/Injection site pain], fever/ongoing fever [Pyrexia], feeling nauseous [Nausea] and her arm was swollen [Peripheral swelling], were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and unknown gender. The patient's drug allergies and pertinent medical history were not reported. On 27-MAY-2014 the patient was vaccinated with ZOSTAVAX, subcutaneously. Concomitant medications were not reported. On 27-MAY-2014, the patient was inadvertently administered ZOSTAVAX which expired was on 24-APR-2014. The pharmacist reported that it was supported. No adverse effects were reported. The outcome of patient was inadvertently administered ZOSTAVAX which expired on 24-APR-2014 and no adverse effects reported was unknown. Additional information has been requested.
Patient fainted post adm. of HPV, Hep A, TDAP vaccines. Waited 20 min accessed and ok to leave office.
Patient presented to the ER having had several episodes of feeling shaky and flushed throughout the day. Spiked temp. Temp in ER 101. Empirically placed on Amoxicillin 500 mg po TID x 7 days due to myelodysplastic syndrome. Advised to avoid flu shots in the future.
We vaccinated Patient with Moderna Booster, but instead of half a dose (0.25ml) we gave full dose (0.5ml). we called to inform  Patient ,he said he feels fine.
The day after the 2nd vaccine patient got horrible cramps and it immediately bleed although it was not time for her period. She bled for 2 days then stopped. This month her period is so painful she thought her appendix ruptured. The pain was so intense it caused her to vomit. Patient's flow is incredibly heavy , thoroughly saturating a super plus tampon in an hour.
Patient is complaining of exceesive pain in arm shot was administered. She says it is interfering with sleep and movement.
This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, nausea, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, nausea and headache was not reported. This report was non-serious.
She was admitted to the hospital with new onset A fib with RVR, pericardial effusion with early tamponade requiring pericardial window with pathology showing inflammation consistent with pericarditis.
severe headache; blurriness; liquid behind her cornea; 2 leaks in the eye; extended artery in left side of head; hearing loss in left ear; arm pain; A spontaneous report received from a Consumer concerning, 65-year-old female patient who has received both doses of the Moderna COVID-19 vaccine and experiencing arm pain, sever headache, blurriness, liquid behind her cornea, 2 leaks in the eye, extended artery in left side of head and hearing loss in her left ear/MedDRA PT: [Sever Headache].   The patient's medical history was not included/ unknown. Patient's concomitant was not included/ unknown.    On 10-FEB-2021, the patient received their second of two planned doses of mRNA-1273 (Batch #: 013L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 11-FEB-2021 Patient Husband reported, that his wife received the Moderna COVID-19 vaccine on 14JAN2021 in her left arm and on the same day experienced arm pain that lasted for 3 days. On 16JAN2021 the patient reported that she had a severe headache and shortly after experienced blurriness. The patient got medical attention and it was reported that she has liquid behind her cornea and 2 leaks in the eye, extended artery in left side of head and hearing loss in her left ear. Symptoms are ongoing and HCP consent was obtained. Patient was not hospitalized.  Treatment information was not provided/ unknown.   Action taken with mRNA-1273 in response to the event was not provided/unknown.   The outcome of the event was unknown/not reported.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
(1) I have had a very distincitve headache every day since the second injection on 3/25/2021.  The headache is at the base of my skull/top of my neck and behind my eyes.  It was chronic for several weeks but now comes and goes but happens a couple to several times each day.  (2) I have been fatigued since the second injeciton on 3/25/2021.  Prior to the second injeciton on 3/25/2021, I had to take between 3mg to 9mg of Melatonin to be able to sleep each night.  Since the second injeciton on 3/25/2021 I have only had to take Melatonin 3 times.  I am chronically tired.  (3) I have intermitent blurred vision that comes and goes.
RIGHT SHOULDER PAIN RADIATING DOWN ARM THROUGH FINGERS, PAIN RATED AS A 7/10 FOR 3 TO FOUR DAYS THEN WENT COMPLETELY NUMB. WENT TO HOSPITAL FOR TREATMENT, RECEIVED VOLTAREN, AND PANTOZOL.